Table 2.
Association of NLR with mortality risk in adults with RA.
| Characteristic | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
| All-cause mortality | ||||||
| NLR (continuous variable) | 1.24 (1.17, 1.31) | <0.001 | 1.21 (1.14, 1.29) | <0.001 | 1.20 (1.14, 1.26) | <0.001 |
| Higher NLR* | 2.11 (1.59, 2.81) | <0.001 | 2.11 (1.59, 2.81) | <0.001 | 2.02 (1.53, 2.66) | <0.001 |
| Cardiovascular mortality | ||||||
| NLR (continuous variable) | 1.29 (1.18, 1.40) | <0.001 | 1.26 (1.15, 1.38) | <0.001 | 1.22 (1.13, 1.31) | <0.001 |
| Higher NLR* | 3.23 (1.82, 5.72) | <0.001 | 2.66 (1.43, 4.96) | 0.002 | 2.48 (1.34, 4.57) | 0.004 |
In model 1, covariates were not adjusted; Model 2 was adjusted by age, sex, race/ethnicity, and educational attainment; Model 3 was adjusted by age, sex, race/ethnicity, educational attainment, BMI, poverty income ratio, smoking status, and health insurance. *Risk of mortality was analyzed compared to lower NLR group.